As a leading learning platform for trends and issues confronting the pharmaceutical industry in Korea and the region, the Conference is an integral part of the event, and will give you a realistic assessment of the industry challenges & strategies.
09.28(Wed) | Time | Title | Organisation | Speaker |
---|---|---|---|---|
Session 1 | 13:30 - 16:40 | Seminar: Strategy for Health Functional Food | Ministry of Food and Drug Safety | |
13:30 - 13:35 | Greeting Speech | Ministry of Food and Drug Safety | 식품안전정책국장 | |
13:35 - 13:40 | Congratulatory Speech | Korea Health Supplements Association | Jung Myungsoo, President of KHSA | |
13:40 - 14:10 | Health Functional Foods Act and policy directions | Ministry of Food and Drug Safety, Health Functional Food Policy Division | Haieun Lee, Deputy Director | |
14:10 - 14:40 | Standards and Specifications for Health Functional Foods | Ministry of Food and Drug Safety, Food Standard Division | Hyung-Wook Chung, Senior Scientific Officer | |
14:40 - 14:50 | Break Time | |||
14:50 - 15:20 | A procedure and evaluation of health functional food ingredients in Korea | National Institute of Food and Drug Safety Evaluation | Taehyung Yoon, Deputy Director | |
15:20 -15:50 | Status of Technical Support for Commercialization of Health Functional Foods | National Institute of Food and Drug Safety Evaluation | Kwon Kwang-Il, Deputy Director | |
15:50 - 16:20 | Inner beauty functional ingredient development with Korean mint extract | Cosmax NBT | Sang Woo Kim, SR. Executive Director | |
16:20 - 16:40 | Q&A | Ministry of Food and Drug Safety |
09.29(Thur) | Time | Title | Organisation | Speaker |
---|---|---|---|---|
Session 2 | 10:30 - 12:30 | KDRA Innovation Policy Research Center (InnoPol) 2022 The 2nd Biohealth Policy Forum | Korea Drug Research Association | |
10:20 - 10:30 | Greeting Speech | Center for Innovation Policy | Young-Hyun Choi, President of InnoPol | |
10:30 - 11:50 | Session 1. Key issues of Korea Bio-health industry's global growth strategy | |||
10:30 - 10:50 | Opportunities and Challenges in AI-Driven Drug Discovery and Development | Dept. of Computer Scienceand Engineering, Korea Univ. | Professor. Jae Woo Kang | |
10:50 - 11:10 | AI and Big Data in New Drug Development | Intlalinks | Country Director. Sun Sik Kim | |
11:10 - 11:30 | Application of AI and big data in drug discovery : case studies | CIMPLRX | CEO. Sung Jin Cho | |
11:30 - 11:50 | Improvement of Drug Discovery Efficiency by AI, Big Data | Pharminogen | CEO. KIM Young Hoon | |
11:50 - 12:00 | Break Time | |||
12:00 - 12:30 | Session 2. Panel Discussion | |||
Suggestion new drug development policies based on Big Data/AI | Center for Innovation Policy | Young-Hyun Choi, President of InnoPol | ||
12:30 | Adjournment | |||
Session 3 | 14:00 - 16:20 | LBP(Live Biotherapeutic Products) Conference Session | Korea Biomedicine Industry Association | |
14:00 - 15:20 | Part 1. Microbiome Development Trends: A commercial perspective of microbiome | |||
14:00 - 14:20 | Current and Future Microbiome Trend: Development trends and its application in real practice | Thermo Fisher Scientific | Keun-Joon Park, Ph.D | |
14:20 - 14:40 | Microbiome therapeutics: Global R&D Trend & Outlook | Genome & Company (Genome & Co.) | Youngjin Seo, CEO | |
14:40 - 15:00 | 국제 마이크로바이옴 규제현황 | CJ Bioscience | Lee Jehee | |
15:00 - 15:20 | Trends and perspectives of microbiome R&D based on germ-free animals. | POSTECH, Department of Life Sciences/Microbiome Core-Facility | Kwang Soon Kim, Ph.D | |
15:30 - 16:20 | Part 2. Microbiome: Exploring commercialization strategics - Panel discussion | |||
15:30 - 16:15 | Microbiome : Exploring commercialization strategics | Panel Discussion | ||
16:15 - 16:20 | Adjournment |
09.30(Fri) | Time | Title | Organisation | Speaker |
---|---|---|---|---|
Session 4 | 10:30 - 12:30 | KPTA Forum - How to proceed regulatory Innovation in the pharmaceutical Industry | Korea Pharmaceutical Traders Association Korea Pharmaceutical Test & Research Institute |
|
10:30 - 11:00 | Introduction of Pharmaceutical regulatory innovation in MFDS | Ministry of Food and Drug Safety, Pharmaceutical Policy division | Kim Sun young, Director | |
11:00 - 11:10 | Break Time | |||
11:10 - 11:40 | Content and Submission of a post-approval Change | Ministry of Food and Drug Safety, Approval Management | Geuna Lee, Director | |
11:40 - 11:50 | Break Time | |||
11:50 - 12:20 | Post-approval change control & Regulatory Innovation | First-Up Solutions Corp. | Kim Hodong, Representative Consultant |
* The above timetable is subject to change without prior notice by the organiser or speakers
* All sessions will be presented in Korean only